Rezultati - Shimin Hu
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia od Qing Wei, Shimin Hu, Sanam Loghavi, Gökçe Törüner, Farhad Ravandi, Zhenya Tang, Shaoying Li, Jie Xu, Naval Daver, L. Jeffrey Medeiros, Guilin Tang
Izdano 2025Artigo -
12
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients od Sanam Loghavi, Khaled Alayed, Tariq N. Aladily, Zhuang Zuo, Siok‐Bian Ng, Guilin Tang, Shimin Hu, C. Cameron Yin, Roberto N. Miranda, L. Jeffrey Medeiros, Joseph D. Khoury
Izdano 2015Artigo -
13
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution od Guilin Tang, Liping Zhang, Bin Fu, Jianhua Hu, Xinyan Lu, Shimin Hu, Ankita Patel, Maitrayee Goswami, Joseph D. Khoury, Guillermo Garcia‐Manero, L. Jeffrey Medeiros, Sa A. Wang
Izdano 2014Artigo -
14
Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia od Zimu Gong, L. Jeffrey Medeiros, Jorge E. Cortés, Lan Zheng, Joseph D. Khoury, Wen Wang, Guilin Tang, Sanam Loghavi, Rajyalakshmi Luthra, Wei Yang, Hagop M. Kantarjian, Shimin Hu
Izdano 2017Carta -
15
TIPE2, a Negative Regulator of Innate and Adaptive Immunity that Maintains Immune Homeostasis od Honghong Sun, Shunyou Gong, Ruaidhrı́ J. Carmody, Anja Hilliard, Li Li, Jing Sun, Li‐ Na Kong, Lingyun Xu, Brendan Hilliard, Shimin Hu, Hao Shen, Xiaolu Yang, Youhai H. Chen
Izdano 2008Artigo -
16
Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors od Wei Wang, Jorge E. Cortés, Pei Lin, Michael W. Beaty, Di Ai, Hesham M. Amin, Timothy J. McDonnell, Chi Young Ok, Hagop M. Kantarjian, L. Jeffrey Medeiros, Shimin Hu
Izdano 2015Artigo -
17
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy od Wei Wang, Jorge E. Cortés, Guilin Tang, Joseph D. Khoury, Sa Wang, Carlos E. Bueso‐Ramos, Joseph A. DiGiuseppe, Zi Chen, Hagop M. Kantarjian, L. Jeffrey Medeiros, Shimin Hu
Izdano 2016Artigo -
18
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm od Wei Wang, Jie Xu, Joseph D. Khoury, Naveen Pemmaraju, Hong Fang, Roberto N. Miranda, C. Cameron Yin, Siba El Hussein, Fuli Jia, Zhenya Tang, Shimin Hu, Marina Konopleva, L. Jeffrey Medeiros, Sa A. Wang
Izdano 2022Artigo -
19
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy od Zimu Gong, L. Jeffrey Medeiros, Jorge E. Cortés, Zi Chen, Lan Zheng, Yan Li, Shi Bai, Pei Lin, Roberto N. Miranda, Jeffrey L. Jorgensen, Timothy J. McDonnell, Wei Wang, Hagop M. Kantarjian, Shimin Hu
Izdano 2017Artigo -
20
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories od Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia‐Manero, Sherry Pierce, Mark J. Routbort, Elias Jabbour, Naveen Pemmaraju, Rashmi Kanagal‐Shamanna, Hatice Gur, Shimin Hu, Zhuang Zuo, L. Jeffrey Medeiros, Hagop M. Kantarjian, Joseph D. Khoury
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Biology
Medicine
Internal medicine
Gene
Genetics
Cancer research
Immunology
Oncology
Gastroenterology
Leukemia
Lymphoma
Cell biology
Biochemistry
Myeloid leukemia
Pathology
Apoptosis
Bone marrow
Cancer
Caspase
Chromosome
Diffuse large B-cell lymphoma
Programmed cell death
Caspase 8
Chemistry
Chemotherapy
Chromosomal translocation
Computer science
Myelodysplastic syndromes
Myeloid
Receptor